Assessing the clinical relevance of drug-drug interactions (DDI) with darolutamide (DARO)

被引：0

作者：

Zurth, C. R. ^{[1
]}

Fizazi, K. ^{[2
]}

Fricke, R. ^{[1
]}

Gieschen, H. ^{[1
]}

Graudenz, K. ^{[1
]}

Koskinen, M. ^{[3
]}

Ploeger, B. A. ^{[1
]}

Prien, O. ^{[1
]}

Smith, M. R. ^{[4
,5
]}

Tammela, T. ^{[6
]}

Shore, N. D. ^{[7
]}

机构：

[1] Bayer AG, Pharmaceut, Berlin, Germany

[2] Univ Paris Sud, Inst Gustave Roussy, Villejuif, France

[3] Orion Corp Orion Pharma, Quantitat Clin Pharmacol, Espoo, Finland

[4] Massachusetts Gen Hosp, Genitourinary Malignancies Program, Boston, MA 02114 USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Univ Tampere, Tampere Univ Hosp, Tampere, Finland

[7] Carolina Urol Res Ctr, Med Oncol, Myrtle Beach, SC USA

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

890P

引用

页数：1

共 50 条

[1] CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS WITH DAROLUTAMIDE
Floyd, Rebecca
Sutton, Jennifer
Olivier, Kara
Zurth, Christian
Smith, Matthew R.
Shore, Neal
ONCOLOGY NURSING FORUM, 2020, 47 (02)
[2] THE CLINICAL RELEVANCE OF DRUG-DRUG AND DRUG-HERBAL INTERACTIONS
Schwab, M.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 1 - 1
[3] Mechanisms and the clinical relevance of complex drug-drug interactions
Roberts, Arthur G.
Gibbs, Morgan E.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 123 - 134
[4] Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
Ferri, Nicola
Colombo, Elisa
Corsini, Alberto
HEMATOLOGY REPORTS, 2024, 16 (01) : 151 - 163
[5] Drug-drug interactions in oncology - prevalence and clinical relevance
Hinnerkort, A.
Liekweg, A.
Muellerleile, U.
Tiede, S.
Bruellke, N.
Jaehde, U.
ONKOLOGIE, 2010, 33 : 1 - 1
[6] Antidepressant drug-drug interactions: Clinical relevance and risk management
Nemeroff, Charles B.
Preskorn, Sheldon H.
DeVane, C. Lindsay
CNS SPECTRUMS, 2007, 12 (05) : 4 - +
[7] Clinical relevance of drug-drug interactions - A structured assessment procedure
van Roon, EN
Flikweert, S
le Comte, M
Langendijk, PNJ
Kwee-Zuiderwijk, WJM
Smits, P
Brouwers, JRBJ
DRUG SAFETY, 2005, 28 (12) : 1131 - 1139
[8] Clinical Relevance of Drug-Drug Interactions in Hospitalized Dermatology Patients
Ganeva, Maria
Gancheva, Tanya
Troeva, Jeni
Kiriyak, Nataliya
Hristakieva, Evgenya
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (04): : 555 - 563
[9] Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Zurth, Christian
Koskinen, Mikko
Fricke, Robert
Prien, Olaf
Korjamo, Timo
Graudenz, Kristina
Denner, Karsten
Bairlein, Michaela
Von Buehler, Clemens-Jeremias
Wilkinson, Gary
Gieschen, Hille
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 747 - 759
[10] AN EVALUATION OF THE CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS IN THE INTENSIVE CARE SETTING
Newsome, Andrea
Hsia, Bernard
CRITICAL CARE MEDICINE, 2019, 47

← 1 2 3 4 5 →